Resibufogenin
CAS No. 465-39-4
Resibufogenin( RBG | Bufotenine | Resibufogenin )
Catalog No. M18571 CAS No. 465-39-4
Resibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 111 | In Stock |
|
| 5MG | 101 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 644 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameResibufogenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionResibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system.
-
DescriptionResibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system. Resibufogenin corrects hypertension in a rat model of human preeclampsia, it not only prevents the advent of hypertension and proteinuria, but also the development of intrauterine growth restriction. Resibufogenina's major metabolic pathway in the human liver is CYP3A4 dominantly mediated 5β-hydroxylation .
-
In Vitro——
-
In Vivo——
-
SynonymsRBG | Bufotenine | Resibufogenin
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number465-39-4
-
Formula Weight384.51
-
Molecular FormulaC24H32O4
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 260.07 mM
-
SMILESCC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C6=COC(=O)C=C6)C)O
-
Chemical Name14,15beta-Epoxy-3beta-hydroxy-5beta-bufa-20,22-dienolide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MY-5445
MY-5445 is a specific inhibitor of phosphodiesterase type 5 (PDE5). MY-5445 selectively inhibits cGMP PDE (Ki:1.3 μM).
-
AWD 12-281
AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).
-
Udenafil
A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
Cart
sales@molnova.com